Professor Mary Slatter
Professor Mary Slatter is a consultant paediatrician in haematopoietic stem cell transplantation at the Great North Children’s Hospital, Royal Victoria Infirmary in Newcastle, specialising in transplant for inborn errors of immunity and related disorders. She is also an Honorary Professor at Newcastle University.
Professor Slatter joined the children’s bone marrow transplant team in Newcastle in 1999 after working as a paediatrician in the Democratic Republic of Congo between 1994 and 1998. She is currently Newcastle’s paediatric haematopoietic stem cell transplant clinical programme director.
Research
Professor Slatter’s research interest is in improving techniques for performing transplants. She has pioneered the use of reduced toxicity conditioning chemotherapy using Treosulfan and the use of mismatched donors following T cell depletion using CD3+TCR alpha beta/CD19+ depletion. She takes an active role in presenting at national and international meetings and publishing findings.
Professor Andrew Gennery
Professor Andrew Gennery is an honorary consultant in paediatric immunology and haematopoietic stem cell transplantation at the Great North Children’s Hospital. He is also Sir James Spence professor of child health, and professor in paediatric immunology and haematopoietic stem cell transplantation at Newcastle University.
Professor Gennery’s clinical training was in Newcastle and London, and he spent a year of post-doctoral studies working with Anne Durandy and Alain Fischer in the Necker Hospital in Paris.
Professor Gennery currently co-chairs the North American CIBMTR Primary Immune Deficiencies, Inborn Errors of Metabolism and other NMMD Working Committee. He is currently paediatric lead on the UKPID Registry Committee.
He has published widely, with over 350 articles on primary immunodeficiency, treatment and outcomes, as well as chapters in major text books and he has written international guidelines including for the treatment of patients with DNA repair disorders.
He is PID sub-section editor of the Orphanet Journal of Rare Diseases, Associate Editor for Frontiers in Immunology and Editorial Board member of Journal of Clinical Immunology.
Professor Gennery is working with Public Health England to introduce Newborn Screening for Severe Combined Immunodeficiencies. He is also the Human Tissue Authority Designated Individual overseeing tissue for therapeutic use within Newcastle.
Research
Professor Gennery’s research interests include immunoreconstitution following haematopoietic stem cell transplant for primary immunodeficiency, long-term outcomes of transplantation for primary immunodeficiency, management of complications post-HSCT, DNA repair disorders and their appropriate treatment, and induction of immune tolerance.
He has supervised over 25 doctoral students.
